zileuton has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmadieh, H; Hafezi-Moghadam, A; Ishibashi, T; Ishikawa, K; Kanavi, MR; Koga, T; Nakama, T; Nakao, S; Ohba, M; Okuno, T; Penninger, JM; Saeki, K; Sasaki, F; Sonoda, KH; Yokomizo, T; Yoshida, S | 1 |
| Bolognese, B; Hubbard, WC; Jackson, JR; Mangar, CA; Marshall, LA; Winkler, JD | 1 |
2 other study(ies) available for zileuton and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Leukotriene B4 promotes neovascularization and macrophage recruitment in murine wet-type AMD models.
Topics: Animals; Benzopyrans; Carboxylic Acids; Choroidal Neovascularization; Disease Models, Animal; Eye; Eye Injuries; Hydroxyurea; Indoles; Lasers; Leucine; Leukotriene B4; Macrophages; Macular Degeneration; Male; Mice; Mice, Knockout; Neovascularization, Pathologic; Receptors, Leukotriene B4; Signal Transduction | 2018 |
The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Female; Granuloma; Hydroxyurea; Inflammation Mediators; Leukotrienes; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Phenanthridines; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Sulfonamides; Triazines | 1998 |